Stocks · Health care · Pharmaceutical Preparations

Vertex Pharmaceuticals

VRTX Clue Score74
United States Fiscal year ends December CIK 0000875320 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Bruce I Sachs
6 Aug 2025
Director
Buy
3,366
$389.84
$1.31M
Bruce I Sachs
6 Aug 2025
Director
Buy
1,634
$389.36
$636.21K
Reshma Kewalramani
6 Aug 2025
CEO & President
Buy
5,710
$389.95
$2.23M
Reshma Kewalramani
6 Aug 2025
CEO & President
Buy
4,290
$389.08
$1.67M
Showing 250 of 1,875 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 1,071
Amendments (4/A) skipped 3
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 213
Sales straight out of an exercise 899
Sales at will 751
Transactions with no price 0
Shares from compensation/vesting 8,011,477
Sales filed before the plan box existed 751
History held since 4 Oct 2006